ClouDr Group Limited (HKG:9955)
Hong Kong · Delayed Price · Currency is HKD 1.000
0.00 (0.00%)
Jan 21, 2026, 4:08 PM HKT
ClouDr Group Revenue
ClouDr Group had revenue of 892.58M CNY in the half year ending June 30, 2025, a decrease of -50.48%. This brings the company's revenue in the last twelve months to 2.26B, down -43.78% year-over-year. In the year 2024, ClouDr Group had annual revenue of 3.49B, down -5.49%.
Revenue (ttm)
2.26B CNY
Revenue Growth
-43.78%
P/S Ratio
0.26
Revenue / Employee
1.85M CNY
Employees
1,218
Market Cap
645.72M HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.49B | -202.44M | -5.49% |
| Dec 31, 2023 | 3.69B | 702.48M | 23.51% |
| Dec 31, 2022 | 2.99B | 1.23B | 70.09% |
| Dec 31, 2021 | 1.76B | 917.61M | 109.35% |
| Dec 31, 2020 | 839.12M | 314.69M | 60.00% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sinopharm Group | 626.85B |
| Charmacy Pharmaceutical | 4.65B |
| Sipai Health Technology | 3.75B |
| IVD Medical Holding | 3.37B |
| Sinco Pharmaceuticals Holdings | 2.73B |
| 160 Health International | 698.59M |
| Ziyuanyuan Holdings Group | 575.61M |
| Wanjia Group Holdings | 163.70M |